STOCK TITAN

Codexis to Participate in the H.C. Wainwright Virtual BioConnect Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Codexis, a prominent enzyme engineering company, will participate in a fireside chat at the H.C. Wainwright BioConnect 2022 Conference, scheduled from January 10-13, 2022. The event will take place virtually, allowing investors and interested parties to access a webcast starting January 10 at 7:00 a.m. ET. This presentation will be archived for 90 days on the company's website. Codexis utilizes its CodeEvolver® platform to enhance enzyme performance across pharmaceuticals, food, and industrial applications, showcasing its commitment to sustainable practices and health improvements.

Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management will participate in a fireside chat at the H.C. Wainwright BioConnect 2022 Conference, being held virtually January 10-13, 2022.

A webcast of the fireside chat will be available on-demand beginning Monday, January 10, 2022 at 7:00 a.m. ET in the Investor Relations section of the Company’s website, http://ir.codexis.com. The webcast will be archived for 90 days following the event.

About Codexis
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover and develop novel, high performance enzymes and novel biotherapeutics. Codexis enzymes have applications in the sustainable manufacturing of pharmaceuticals, food, and industrial products; in the creation of the next generation of life science tools; and as gene therapy and biologic therapeutics. The Company’s unique performance enzymes drive improvements such as: reduced energy usage, waste generation and capital requirements; higher yields; higher fidelity diagnostics; and more efficacious therapeutics. Codexis enzymes enable the promise of synthetic biology to improve the health of people and the planet. For more information, visit www.codexis.com.

Investor Relations Contact:
Argot Partners
Brendan Strong/Carrie McKim
(212) 600-1902
Codexis@argotpartners.com


FAQ

When is Codexis participating in the H.C. Wainwright BioConnect 2022 Conference?

Codexis will participate in the H.C. Wainwright BioConnect 2022 Conference from January 10-13, 2022.

What time does the Codexis fireside chat start?

The Codexis fireside chat will begin on January 10, 2022, at 7:00 a.m. ET.

Where can I watch the Codexis fireside chat?

You can watch the Codexis fireside chat on-demand in the Investor Relations section of their website starting January 10, 2022.

How long will the Codexis webcast be available?

The Codexis webcast will be archived for 90 days following the event.

What is the significance of Codexis's participation in the conference?

Codexis's participation highlights its advancements in enzyme engineering and its role in synthetic biology, focusing on sustainable manufacturing and health improvements.

Codexis, Inc.

NASDAQ:CDXS

CDXS Rankings

CDXS Latest News

CDXS Stock Data

368.64M
79.57M
2.23%
79.83%
2.4%
Biotechnology
Industrial Organic Chemicals
Link
United States of America
REDWOOD CITY